Rosuvastatin Tablet, Film Coated
Product Images NDC 50090-7483

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 5 technical images submitted to the FDA as part of the official labeling for Rosuvastatin (NDC 50090-7483). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by A-s Medication Solutions, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Figure-01 (Figure 1)

Figure-01 (Figure 1)
This text appears to provide statistical data on two groups (RSV and Placebo) and their corresponding number at risk and years observed. The values include point estimates, confidence intervals, and p-values. The RSV group seems to have a lower risk ratio compared to the Placebo group based on the provided data.*
FDA Label Image

Figure-02 (Figure 2)

Figure-02 (Figure 2)
This text provides information on a clinical trial comparing the effects of Rosuvastatin 20 mg versus Placebo 20 mg on various cardiovascular outcomes. The results include the number of events for the primary endpoint and specific outcomes like cardiovascular death, nonfatal stroke, nonfatal MI, hospitalized unstable angina, and arterial revascularization. It also presents hazard ratios, confidence intervals, and p-values for each outcome, indicating the effectiveness of Rosuvastatin in reducing cardiovascular events compared to placebo. The study involves a total of 8901 participants and highlights important data related to cardiovascular mortality and morbidity.*
FDA Label Image

Figure-02 (Figure 3)

FDA Label Image

Label Image (Lbl500907483)

FDA Label Image

Structural Formula (Rosuvastatin Str)

Structural Formula (Rosuvastatin Str)
Not available.*

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.